Company news

Tarsus Pharmaceuticals, Inc. news in 2020

Tarsus Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.

Tarsus Pharmaceuticals, Inc. Announces Type C Meeting with FDA Regarding NDA Submission Requirements for Lead Candidate TP-03

December 22, 2020

Tarsus Pharmaceuticals, Inc. Announces Inclusion in the Russell 3000® Index and Russell 2000® Index

December 20, 2020

Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors

November 18, 2020

Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference

November 12, 2020

Tarsus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise by the Underwriters of Option to Purchase Additional Shares

October 19, 2020

Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

October 14, 2020

Decks in 2020

Jefferies Virtual London Healthcare Conference 2020
Conference · 21 slides · Nov 17, 2020